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Protein kinase D (PKD) mediates signal transduction
downstream from phospholipase C and diacylgly-
cerol (DAG). PKDs are activated by hormones and
stress in cell lines, but little is known about PKD func-
tions and regulation in vivo. Here, we show that
DKF-2, a C. elegans PKD, regulates innate immunity.
Animals lacking DKF-2 were hypersensitive to killing
by bacteria that are pathogens of C. elegans and
humans. DKF-2 induced 85 mRNAs, which encode
antimicrobial peptides and proteins that sustain
intestinal epithelium. Induction of immune effector
mRNAs by DKF-2 proceeded via PMK-1 (p38 Map-
kinase)-dependent and -independent pathways.
TPA-1, a PKCd homolog, regulated activation and
functions of DKF-2 in vivo. Therefore, DKF-2 provides
amolecular link that couples DAGsignaling to regula-
tion of immunity. This intersection between DAG-
TPA-1-DKF-2 and PMK-1 pathways enables inte-
grated immune responses to multiple stimuli. Thus,
a PKD mobilizes activation of host immune defenses
against pathogens by previously unappreciated
signaling pathways and mechanisms.
INTRODUCTION
Diacylglycerol (DAG) is generated when hormones or other
stimuli activate phospholipase Cb (PLCb), PLCg, or PLC3. DAG
binds to and promotes the activation of eight protein kinase
C isoforms. PKCs a, bI, bII, and g are activated by DAG and
Ca2+, and PKCs d, 3, h, and q are stimulated by DAG alone
(Newton, 2003). PKCs regulate physiological processes by
phosphorylating Ser or Thr hydroxyl groups in effector proteins.
DAG signals are also disseminated by protein kinase D (PKD),
another Ser-Thr kinase (Rozengurt et al., 2005; Wang, 2006).
Three genes encode homologous PKD isoforms (PKDs 1–3) in
mammals. Like PKCs, PKDs have a C-terminal kinase domain
preceded by C1 domains, which bind DAG or phorbol
12-myristate 13-acetate (PMA). Upon PLC activation, C1
domains mediate translocation of PKDs and PKCs from the cyto-
plasm to DAG-enriched membranes. DAG-activated PKC phos-
phorylates the PKD activation loop (A-loop), thereby switching onD kinase catalytic activity (Rozengurt et al., 2005). Thus, PKDs are
PKC effectors.
PKDs convert transient DAG signals into prolonged physiolog-
ical effects because activity persists as the kinases translocate
to various intracellular locations (Rozengurt et al., 2005; Wang,
2006). Because PKDs and PKCs phosphorylate different
substrates (Nishikawa et al., 1997), PKDs place distinct effectors
and physiological processes under DAG control.
Hormones that bind Gq-coupled receptors elicit PKD activa-
tion in cell lines (Rozengurt et al., 2005), suggesting that PKDs
regulate many facets of mammalian physiology. In cell culture,
PKDs mediate prosurvival signaling (NFkB activation) induced
by oxidative stress, control fission of Golgi membrane vesicles,
modulate antigen-activated signaling in B and T cells, regulate
JNK/c-jun-dependent proliferation, govern motility and adhe-
sion, and promote nuclear export of type II histone deacetylases
(HDACs) (Rozengurt et al., 2005; Vega et al., 2004; Wang, 2006).
HDACs 5 and 7 are PKD substrates; their phosphorylation dere-
presses gene transcription.
It is not known whether roles assigned to PKDs are major or
minor functions of D kinases in normal cells, or whether PKDs
regulate NFkB, vesicle fission, and other facets of cell physiology
ubiquitously or in a few tissues. For example, HDACs were not
phosphorylated when PKCs were activated in PKD-deficient,
avian B lymphoma cells (Liu et al., 2007). However, proliferation,
oxidative stress signaling, c-junactivity, and HDAC nuclear export
were not affected. Thus, PKD function(s) in B cells remain unclear.
Likewise, little is known about PKD functions and effectors in
normal tissues of intact animals. Thus, elucidation of in vivo regu-
lation, physiological roles, and effectors of PKDs are major chal-
lenges in comprehending DAG-regulated signal transduction.
Problems in PKD-mediated signaling can be addressed by
studying C. elegans. C. elegans employs signaling molecules,
mechanisms, and pathways that are conserved in mammals
(Kim et al., 2002; Nicholas and Hodgkin, 2004; Schulenburg
et al., 2004). Recently, we characterized a 120 kDa C. elegans
PKD named DKF-2 (for D kinase family) (Feng et al., 2007); the
corresponding C. elegans gene is named dkf-2. DKF-2 (1070
amino acids) and human PKDs contain conserved regulatory
(C1) and kinase domains that are 75% identical in amino acid
sequence (Figure S1 available online). In transfected cells,
DKF-2 binds DAG or PMA at plasma membrane and is activated
when PKC phosphorylates two A-loop serines (Feng et al., 2007).
Human and C. elegans PKDs have similar substrate specificities.
Thus, DKF-2 is a prototypical PKD.Immunity 30, 521–532, April 17, 2009 ª2009 Elsevier Inc. 521
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gene (dkf-2(pr3) allele) has a null phenotype: DKF-2 protein is not
expressed in the deletion mutant (Feng et al., 2007). However,
the animals are viable, fertile, and develop normally. Conse-
quently, null animals and null mutants reconstituted with a WT
dkf-2 transgene can be exposed to stimuli to discover physiolog-
ical roles of DKF-2, to identify regulators and effectors of DKF-2,
and to illuminate mechanisms by which DKF-2 controls biolog-
ical processes.
We discovered that DKF-2 plays an important physiological
role in normal intestinal cells. The PKD linked signals carried by
DAG to induction of innate immunity. DKF-2 was potently acti-
vated when a bacterial pathogen colonized the gut. Activated
DKF-2 contributed to innate immunity by inducing expression
of many genes that protect host intestinal epithelial cells against
bacterial attack. TPA-1, a PKCd homolog, exclusively regulated
activation and functions of DKF-2 in vivo. Induction of immune
effector mRNAs by DKF-2 proceeded via PMK-1 (p38 Map-
kinase)-dependent and -independent pathways. The intersec-
tion between signals disseminated by DKF-2 and the stress-
activated p38 cascade places PMK-1 and its multitude of
downstream effectors under (partial) control of stimuli that acti-
vate PLCs. Overall, the results identify a unique signaling
pathway and illuminate mechanisms by which DAG, a specific
PKC isoform, and PKD enhance immune responses against
pathogens.
RESULTS
DKF-2 Is Differentially Expressed in Intestine
A 1.4 kb segment of genomic DNA, which flanks the 50 end of the
dkf-2 structural gene, was cloned upstream from a green fluores-
cent protein (GFP) reporter gene in a C. elegans expression
vector. The minigene is designated dkf-2::Gfp; it includes dkf-2
promoter and enhancer DNA and an open reading frame encod-
ing full-length GFP. Several lines of transgenic C. elegans ex-
hibited robust dkf-2 promoter activity in 18 cells that constitute
the intestine (Figure S2). Modest GFP fluorescence was de-
tected in four neurons (Figure S2, asterisks). The dkf-2 promoter
also directed synthesis of full-length DKF-2-GFP in intestinal
cells of late embryos, larvae, and adult C. elegans. The kinase
was dispersed in cytoplasm and slightly enriched along apical
surfaces of cells (Figure 1A). Weak fluorescence was detected
in neurons described in Figure S2 when exposure time was
increased (not shown). DKF-2-GFP was not evident in other
cells.
DKF-2-GFP was expressed in HEK293 cells. A DAG surrogate,
PMA, induced transfer of DKF-2-GFP from cytoplasm to
membranes and elicited a 4- to 5-fold increase in catalytic
activity (Figures 1B and 1C). PMA-induced kinase activation
was abolished by incubating cells with GF109203X, an inhibitor
of DAG-activated PKCs. Properties of DKF-2-GFP and WT
DKF-2 were similar (Figures 1B and 1C), demonstrating that
the fusion protein is properly folded, correctly regulated, and fully
functional.
The results indicate that DKF-2 is predominantly expressed in
intestine and suggest that a dkf-2::dkf-2-Gfp transgene could be
used to elucidate cell-specific physiological functions of DKF-2
in vivo.522 Immunity 30, 521–532, April 17, 2009 ª2009 Elsevier Inc.A
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Figure 1. DKF-2-GFP Is Fully Functional and Selectively Expressed
in Intestine
(A) Animals expressing a dkf-2::dkf-2-Gfp transgene were created. GFP-
derived fluorescence was recorded with a Zeiss Axio Imager Z1 microscope
and AxioVision software. Arrows mark anterior and posterior ends of the intes-
tine. Image 1 (L2 larva) and image 3 (late embryo) show DKF-2-GFP is
dispersed in intestinal cells. Images 2 and 4 are Nomarski microscopy images
of animals shown in panels 1 and 3, respectively.
(B) An immunoblot containing cytosolic (S) and membrane (P) proteins (30 mg/
lane) isolated from HEK293 cells expressing DKF-2-GFP (lanes 1–4) or DKF-2
(lanes 5–8). Cells were incubated with 0.3 mM PMA (10 min) as indicated.
Cytosol and membranes were isolated as previously reported (Feng et al.,
2007). The blot was probed with anti-DKF-2 IgGs and chemiluminescence
signals were recorded on X-ray film.
(C) Transfected cells expressing DKF-2-GFP or DKF-2 were treated with
0.3 mM PMA or vehicle (basal) for 10 min. Duplicate samples of cells were incu-
bated with pan-PKC inhibitor GF109203X for 1 hr prior to PMA addition. Cells
were lysed and DKF-2 proteins were immunoprecipitated and assayed for
catalytic activity as described in Experimental Procedures. An immunoblot
shows that similar amounts of DKF-2 were used in each assay (bottom).
Increases in apparent Mr of DKF-2 in PMA-treated cells (B, C) are due to phos-
phorylation catalyzed by PKCs and other protein kinases. Error bars corre-
spond to standard error of the mean (SEM); n = 4.
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Figure 2. DKF-2-Deficient Animals Are Hypersensitive to Pathogenic Bacteria; Elevated DKF-2-GFP Expression Confers Pathogen
Resistance
(A) Survival curves for WT (N2), dkf-2(pr3) null, transgenic (dkf-2::dkf-2-Gfp and dkf-2(pr3);dkf-2::dkf-2-Gfp)C. elegans fed with PA14. Assays were replicated four
times with similar results; typical data are shown.
(B) Proteins (30 mg/lane) from the indicated animals were separated by denaturing electrophoresis and transferred to a PVDF membrane. The blot was probed
with anti-DKF-2 IgGs.
(C) Survival curves for animals fed with E. faecalis OG1RF. Assays were replicated three times with similar results.
(D) WT or transgenic animals were fed with OP50, OP50 HK, or PA14 as indicated. Animals were disrupted in a French press, with buffer containing 1% Triton
X-100. DKF-2 and DKF2-GFP were immunoprecipitated from samples containing 0.5 mg protein (from equal numbers of animals) by anti-DKF-2 IgGs. Precip-
itated proteins were assayed for kinase activity. Error bars correspond to standard error of the mean (SEM); n = 4.Immunity 30, 521–532, April 17, 2009 ª2009 Elsevier Inc. 523DKF-2 Regulates Responses to Ingested Bacterial
Pathogens
C. elegans feeds on soil microbes and uses an innate immune
system to eliminate pathogenic bacteria (Nicholas and Hodgkin,
2004; Schulenburg et al., 2004). The nematode’s intestinal cells
contribute many effectors of innate immunity and provide
a model for studying host defense mechanisms against human
pathogens. To determine whether PKD affects pathogen resis-
tance, WT, dkf-2(pr3) null animals, and transgenic C. elegans
expressing elevated DKF-2-GFP (WT background) were fed
P. aeruginosa strain 14 (PA14). DKF-2-depleted C. elegans was
hypersensitive to killing by Gram-negative PA14 (Figure 2A).
Half of dkf-2 null animals died after 48 hr and only 18% survived
62 hr. In contrast, 79% and 50% of WT C. elegans were alive
after feeding on PA14 for 48 and 62 hr, respectively. An inte-
grated transgene directed accumulation of DKF-2-GFP to a level
that exceeded WT DKF-2 by 3.6-fold (Figure 2B). Elevated
DKF-2 protected C. elegans, supporting 92% and 71% survivalafter animals consumed PA14 for 48 and 62 hr, respectively
(Figure 2A). Expression of DKF-2-GFP in a dkf-2(pr3) null back-
ground caused a similar increase in PA14 resistance (Figure 2A).
Dkf-2 null animals were hypersensitive to killing by a Gram-
positive pathogen, E. faecalis OG1RF. After feeding on OG1RF
for 94 hr, only 9% of DKF-2-depleted animals survived, whereas
57% of WT C. elegans and 93% of animals overexpressing DKF-
2-GFP were alive (Figure 2C). S50 values (hours of pathogen
ingestion that yield 50% survivors) were 77, 97, and 131 hr for
dkf-2(pr3) null, WT, and transgenic animals, respectively. Transi-
tion from DKF-2 deficiency to DKF-2 surfeit extended survival
time 70% in a toxic environment. Thus, DKF-2, a DAG-
controlled PKD, upregulates innate immunity.
Pathogens Potently Activate DKF-2
WT and transgenic animals were fed PA14 (strong pathogen),
E. coli OP50 (standard food, but a mild pathogen), or nonpatho-
genic, heat-killed OP50 (OP50 HK). In both WT C. elegans and
Immunity
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(1) extremely low when OP50 HK was consumed, (2) markedly
increased by a diet of living OP50, and (3) induced to maximal
levels by ingestion of PA14 (Figure 2D). Signaling pathways gov-
erning DKF-2 activity were almost completely inactive when food
was nonpathogenic. Weak and strong pathogens differentially
induced intermediate and large increases, respectively, in cata-
lytic activity of endogenous DKF-2. PA14 infection increased
DKF-2 kinase activity 6.5-fold relative to activity in animals fed
OP50 (Figure 2D). The increase is 100- fold relative to DKF-2
activity in animals consuming OP50 HK.
In parallel with the increase in DKF-2-GFP protein (Figure 2B),
transgenic animals fed OP50 expressed a 7-fold higher level of
D kinase activity than did WT, OP50-fed C. elegans (Figure 2D).
PA14 infection elicited a further 2.6-fold increase in kinase
activity in animals expressing DKF-2-GFP. Maximal PA14-stim-
ulated D kinase activity in transgenic nematodes is 300-fold
higher than DKF-2 catalytic activity in WT animals fed OP50
HK. In transgenic animals, overexpressing DKF-2-GFP, consti-
tutive high-level expression of DKF-2 kinase activity prior to
infection and further (2.6-fold) amplification of enzyme activity
upon PA14 infection were linked to enhanced protection against
pathogen-mediated killing (Figure 2A).
Although dkf-2(pr3) null animals were hypersensitive to PA14-
mediated killing (Figure 2A), they lived 40% longer than did WT
C. elegans on plates containing viable OP50 or OP50 HK
(Figure S3A; Feng et al., 2007). In contrast, increased DKF-2
activity promoted resistance to PA14, but slightly diminished life-
span (S50 declined by 0.5–1 day) when animals were fed viable
OP50 or OP50 HK (Figure S3B). Opposing effects of diminished
and increased DKF-2 activity on lifespan and pathogen resis-
tance show that PA14 killing assays reflect the impact of DKF-2
on the defense against attacking pathogens, not DKF-2-depen-
dent changes in aging.
Overall, experiments presented in Figures 2A–2D reveal that
DKF-2, a prototypic DAG-activated PKD, links a potent stimulus,
bacterial attack on the intestinal epithelium, to a fundamentally
important in vivo physiological process, innate immunity.
DKF-2 Induces Expression of 85 Genes that Defend
against Bacterial Infection
When bacterial pathogens populate the intestinal lumen, C. ele-
gans induces gene expression that promotes survival (Nicholas
and Hodgkin, 2004; Schulenburg et al., 2004; Troemel et al.,
2006). Activated, intestinal DKF-2-GFP enhanced pathogen resis-
tance in transgenic animals (Figure 2). Therefore, genome-wide
microarray analysis was used to determine when DKF-2 induces
mRNAs encoding immuneeffectors.Wediscoveredthat increased
DKF-2 activity induced 3- to 30-fold increases in 85 mRNAs
(Table 1). Many DKF-2-induced mRNAs encode proteins involved
in innate immunity (Schulenburg et al., 2004). These proteins
constitute eight classes of effectors that apparently produce an
integrated response to bacterial pathogens (Figure S4).
DKF-2 activation diminished expression of genes controlling
nonimmune stress responses (Table 2). mRNAs encoding heat
shock proteins (HSPs 16.2, 16.41, and 70), toxic metal-induced
metallothionein (MTL-1), ubiquitin, and ubiquitin E3 ligases
(UBQ-1, CUL-2, and F43C11.7) declined 70%–90%. Transcripts
encoding proteins that govern DNA repair, chromatin remodel-524 Immunity 30, 521–532, April 17, 2009 ª2009 Elsevier Inc.ing, RNA and DNA unwinding and modification, nutrient delivery
to oocytes (vitellogenins), meiotic spindle formation, and protein
translation were also suppressed 70%–95%.
DKF-2 Induces mRNAs that Increase in PA14-Infected
C. elegans
Effects of DKF-2 on gene expression were independentlyassessed
by quantitative real-time PCR (qRT-PCR) analysis. Amounts of
20 mRNAs (selected fromTable 1) were measured inWTC.elegans
and animals overexpressing DKF-2-GFP. Concentrations of
selected mRNAs increased 2- to 42-fold when DKF-2 activity was
elevated (Table 3A). Large, DKF-2-dependent increases in abun-
dance of mRNAs encoding CLEC-52, ABF-2, and SPP-18 antimi-
crobial proteins were documented (Table 3A). Although mRNA
abundance varied somewhat between microarray and qRT-PCR
experiments (Tables 1 and 3A), the data demonstrate that DKF-2
potently induces multiple classes of immune effector mRNAs.
Next, we determined whether DKF-2-regulated mRNAs were
elevated in PA14-infected C. elegans. We measured concentra-
tions of 15 candidate DKF-2-PA14-induced mRNAs by qRT-
PCR. DKF-2 activation and PA14 infection increased the abun-
dance of 12 mRNAs (Table 3A). Two transcripts were divergently
regulated: DKF-2 elevated CLEC-52 mRNA 39-fold, whereas
PA14 infection caused a 2.3-fold increase; conversely, PA14
and DKF-2 triggered 48- and 3.2-fold elevations, respectively,
in GST-38 mRNA. Thus, most DKF-2 effectors contribute to
host responses to PA14 infection. Some DKF-2-controlled
proteins may target different pathogens or regulate distinct fac-
ets of cell physiology. A limited ability to induce GST-38 and
other immune effector mRNAs (see below) suggests that
DKF-2 regulates expression of a subset of antipathogen genes.
DKF-2 Regulates Accumulation of PA14-Induced
Transcripts during Infection
Pathogen proliferation in intestinal lumen elicits immune
responses by activating the PMK-1, DBL-1 (TGF-b), and other
signaling pathways (Nicholas and Hodgkin, 2004; Schulenburg
et al., 2004). Because concentrations of PA14-induced mRNAs
can be controlled by two or more signaling systems, logical
predictions are that increased DKF-2 activity will synergize
with infection to promote supranormal accumulation of some
PA14-induced mRNAs, and that DKF-2 deficiency will reduce
(but not eliminate) PA14-mediated induction of a subset of
immune effector mRNAs.
Predictions were tested by quantifying expression of 11 path-
ogen-induced mRNAs after feeding dkf-2(pr3), WT, and trans-
genic (dkf-2::dkf-2-Gfp) C. elegans with PA14. Enhanced DKF-2
activity elicited increases in levels of all mRNAs (Table 3B).
Elimination of DKF-2 substantially reduced the abundance of
seven PA14-induced mRNAs encoding antimicrobial proteins.
Thus, DKF-2 regulates the amplitude of accumulation of immune
effector mRNAs induced by bacterial pathogen.
DKF-2 Controls mRNA Expression by P38-Dependent
and -Independent Pathways
A protein kinase cascade, composed of NSY-1, SEK-1, and
PMK-1 (homologs of human ASK-1, MEK3, and p38 MAP-
kinase, respectively), plays a critical role in innate immunity
(Kim et al., 2002). Mutations in nsy-1, sek-1, or pmk-1 cause
Immunity
PKD Regulates C. elegans Innate ImmunityTable 1. DKF-2 Induces 3- to 30-fold Increases in 85 mRNAs
Gene Family and
Sequence Name Gene Name Fold Inductiona
Abf (antibacterial factor related)
C50F2.10 abf-2 9.7 (-)
Claudin like
C09F12.1 clc-1 6.7 (+)
F10A3.1 18.8 (+)
C-type lectins
B0365.6 clec-41 4.1 (+)
B0218.8 clec-52 11.8 (+)
Y46C8AL.5 clec-72 8.5 (nd)
Y54G2A.9 clec-81 7.6 (+)
R07B1.10 lec-8 3.8 (+)
M02F4.7 6.5 (+)
W03D2.6 3.4 (+)
CaeNaCin (Caenorhabditis bacteriocin)
R09B5.3 cnc-2 5.0 (nd)
R09B5.8 cnc-3 5.7 (+)
F53H2.2 cnc-7 4.6 (nd)
F41E7.8 cnc-8 5.2 (+)
FMRFamides (FMRF-like Peptides)
K02G10.4 flp-11 5.0 (-)
F39H2.1 flp-22 5.1 (-)
C24A1.1 flp-24 4.8 (nd)
Transcription Factors
W10D5.1 mef-2 3.8 (+)
C10E2.3 hda-4 4.4 (+)
C06C6.4 nhr-63 3.4 (+)
K03C7.2 fkh-9 4.1 (+)
Golgi Trafficking
F45E4.1 arf-1.1 10.3 (+)
W05H7.3 sedl-1 3.2 (+)
T02E1.7 5.6 (nd)
NLP (Neuropeptide-Like Protein)
C01C4.1 nlp-1 4.0 (+)
F48C11.3 nlp-3 3.7 (+)
F18E9.2 nlp-7 3.4 (+)
Y47D3B.2 nlp-21 4.7 (+)
B0213.3 nlp-28 4.0 (+)
B0213.5 nlp-30 7.0 (+)
B0213.17 nlp-34 9.4 (nd)
SaPosin-like Protein
T25C12.2 spp-9 18.2 (+)
F27C8.4 spp-18 4.2 (+)
Aspartyl Proteases
F21F8.4 4.0 (+)
Y39B6A.24 13.2 (+)
Transporters
F58E1.6 nhx-6 31.7 (+)
F28F9.3 (ATP) 4.5 (nd)
C47A4.2 (nucleoside) 3.9 (nd)Table 1. Continued
Gene Family and
Sequence Name Gene Name Fold Inductiona
Y51A2D.4 (H+-myoinositol) 6.6 (nd)
T27D12.1 (Na-sialic acid) 3.5 (nd)
F10G7.5 (carboxylate) 3.5 (nd)
Y54G2A.4 (sugar) 4.6 (+)
K01H12.2 (ADP-ATP) 5.6 (+)
GST (Glutathione S-Transferase)
F11G11.3 gst-6 3.6 (+)
F35E8.8 gst-38 10.2 (+)
K01D12.11 cdr-4 4.4 (+)
CC domains
F08D12.3a 3.9 (nd)
Y110A2AL.9 4.5 (nd)
TIL domain
B0238.12 6.1 (nd)
C25E10.8 4.9 (+)
fip (Fungus-Induced Protein)
C06E1.5 fip-3 5.8 (nd)
ShKT domains
C14C6.2 4.0 (+)
C14C6.5 4.8 (+)
C49G7.3 4.0 (+)
E04D5.4 6.9 (nd)
F01D5.2* 5.0 (nd)
F01D5.3* 4.8 (nd)
F01D5.5* 5.9 (+)
F15A4.6 4.1 (nd)
F49F1.1 4.3 (+)
F49F1.5 4.7 (+)
T20G5.8 4.2 (+)
T24B8.5* 8.5 (+)
Unknown
B0348.2 7.9 (nd)
B0496.7 6.1 (+)
C02E7.6 6.4 (nd)
C39D10.2 4.0 (+)
C44B11.4 3.9 (nd)
C45G9.6b 4.0 (nd)
C49G7.7 4.9 (nd)
D2007.1* 3.5 (+)
F09E10.1 5.2 (nd)
F42G9.6b 6.7 (nd)
F47D12.6 5.3 (+)
F53E10.4 4.6 (+)
K04F1.9* 5.1 (nd)
K11H12.4 7.1 (+)
M05B5.2 4.3 (+)
T24C4.4 4.6 (+)
T27F6.7 3.2 (nd)
(Continued on next page)Immunity 30, 521–532, April 17, 2009 ª2009 Elsevier Inc. 525
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PKD Regulates C. elegans Innate Immunitysupersensitivity to killing by pathogens. Because (1) DKF-2
induced several PMK-1-regulated mRNAs (Table 1, asterisks;
Troemel et al., 2006), (2) DKF-2-regulated mRNAs increase in
PA14-infected animals (Table 3), and (3) PMK-1 mediates
immune responses to PA14, we determined whether signals
disseminated by DKF-2 intersect with the PMK-1 pathway.
After feeding on PA14 for 72 hr, 75% of animals expressing
elevated DKF-2-GFP protein and activity survived, but nearly all
DKF-2-depleted animals died (Figure 3A). S50 decreased from
80 to 50 hr. PA14 infection caused populations of PMK-1-defi-
cient animals to decline more rapidly (S50 = 27 hr, Figure 3A).
However, dkf-2::dkf-2-Gfp transgene expression only slightly
altered the pmk-1(km25) null phenotype; PA14 killed all animals
within 48 hr (S50 = 31 hr, Figure 3A). Survival curves for pmk-
1(km25) null and pmk-1(km25), dkf-2(pr3) double null mutants
were similar. Thus, PMK-1 is indispensable for DKF-2-induced
innate immunity. The results reveal a unique intersection between
DAG-controlled and p38-mediated signal transductionpathways.
Loss of PMK-1 could ablate expression of a few critical DKF-2
effectors or suppress accumulation of many DKF-2-inducible
mRNAs. To distinguish between these possibilities, we
measured amounts of 17 DKF-2-regulated mRNAs in animals
expressing a dkf-2::dkf-2-Gfp transgene in WT or pmk-1 null
backgrounds. PMK-1 deficiency eliminated or suppressed
induction of 15 mRNAs (Figure 3B). Thus, PMK-1 links DKF-2
to a majority of its downstream effectors. Knowledge of p38
signaling was advanced by adding 15 genes (Figure 3B) to the
constellation of PMK-1 effectors. DKF-2 promoted large
increases in ARF-1.1, SPP-9, and F10A3.1 mRNA in animals
lacking PMK-1. Thus, DKF-2 controls expression of immune
effectors by PMK-1-dependent and -independent mechanisms.
When mutations inhibit thedaf-2-age-1signaling pathway, DAF-
16 (a target transcription factor) accumulates in nuclei. DAF-16
elicits gene expression that increases C. elegans lifespan and
imparts resistance to pathogens (Garsinet al., 2003). DKF-2 deple-
tion enhances accumulation of DAF-16 in gut nuclei and increases
lifespan40% (Feng et al., 2007). If DAF-16 mediates regulation of
immunity by DKF-2, then a daf-16(mgDf50) loss-of-function
mutant will be hypersensitive to killing by PA14; dkf-2(pr3) null
animals should exhibit enhanced resistance to PA14. However,
PA14 killed WT and daf-16(mgDf50) mutants with similar kinetics
Table 1. Continued
Gene Family and
Sequence Name Gene Name Fold Inductiona
Y37A1A.2* 5.4 (nd)
Y47G6A.15 4.2 (nd)
Y66D12A.24 3.6 (+)
ZK6.8 6.1 (+)
Microarray analysis measured the abundance of mRNAs in animals ex-
pressing an integrated dkf-2::dkf-2-Gfp transgene (relative to mRNA
levels in WTC. elegans). Animals were fed E. coli OP50. Asterisk indicates
previously reported PMK-1-regulated mRNAs.
a Symbols in parentheses indicate: (+), mRNA expressed in intestine; (nd),
mRNA expression pattern not determined; (-) mRNA expressed in various
cells, but not intestine. Designations are based on data provided by
WormBase (http://www.wormbase.org) and the Genome Sciences
Center MultiSAGE C. elegans database (http://www.elegans.bcgsc.ca).526 Immunity 30, 521–532, April 17, 2009 ª2009 Elsevier Inc.(Figure S5). DKF-2-depleted animals are hypersensitive, not resis-
tant, to PA14 (Figure 2A). Survival curves for DKF-2-deficient
animals and dkf-2(pr3) null, daf-16(mgDf50) double mutants were
similar (Figure S5). Moreover, elevated DKF-2 activity increased
PA14 resistance in WT (Figure 2A) and daf-16(mgDf50) mutant
(not shown) backgrounds. Thus, DKF-2 induces immune effector
mRNAs via PMK-1-dependent and -independent pathways, but
not by DAF-16-mediated transcription.
A-Loop Phosphorylation Is Required for DKF-2-
Mediated Induction of Antimicrobial mRNAs
Nonactivated PKDs control some physiological processes by
serving as scaffolds (Medeiros et al., 2005; Zhang et al., 2005).
To determine whether DKF-2 kinase activity is required to induce
immune effectors, we characterized animals expressing dkf-
2::dkf-2(Ala925Ala929)-Gfp and dkf-2::dkf-2(Glu925Glu929)-
Gfp transgenes in a dkf-2 null background. DKF-2 is acti-
vated when PKC phosphorylates the A-loop (Ser925 and
Ser929) of the D kinase (Feng et al., 2007). Consequently,
DKF-2(Ala925Ala929)-GFP cannot be activated. DKF-2
(Glu925Glu929)-GFP is constitutively active because Glu for Ser
substitutions mimic phosphorylation of A-loop serines. We tested
the mutant kinases’ ability to induce immune effector mRNAs.
DKF-2(Ala925Ala929)-GFP was abundantly expressed (Fig-
ure 3D), but expression of effector mRNAs was not altered
(Figure 3C). A low amount of DKF-2(Glu925Glu929)-GFP accu-
mulated in transgenic animals (15% relative to WT DKF-2).
However, immune effector mRNA levels increased 2- to 7-fold
in animals expressing constitutively active D kinase. Thus,
A-loop phosphorylation and DKF-2 activity are required in vivo
to induce expression of genes involved in combating pathogens.
DKF-2 Promotes Activation of PMK-1
A-loop phosphorylation at Thr191 and Tyr193 activates PMK-1.
Thus, PMK-1 activity was monitored by immunoblot analysis, via
IgGs that bind a diphosphorylated A-loop peptide shared by
human p38 MAP kinase and C. elegans PMK-1 (Figure 3E).
PMK-1 activity was low in WT C. elegans and animals overex-
pressing DKF-2(Ala925Ala929)-GFP (dkf-2 null background).
However, elevated expression of WT DKF-2-GFP or reconstitu-
tion of a dkf-2 null mutant with DKF-2(Glu925Glu929)-GFP eli-
cited a 3- to 4-fold increase in diphosphorylated PMK-1 (Fig-
ure 3E). Thus, a surfeit of DKF-2 activates PMK-1 and
enhances resistance to PA14 (Figure 3A).
DKF-2 depletion diminished the S50 value for PA14-mediated
killing by 15 hr (Figure S6). Disruption of the pmk-1 gene reduced
S50 by 30 hr. The more severe phenotype evidently arises from
the ability of the PMK-1 pathway to receive and integrate signals
from several inputs. PMK-1 is activated by PA14 infection and
(by analogy with p38 MAP kinase) stress, autocrine, and para-
crine signals generated as infection progresses. DKF-2 couples
signals carried by DAG to upregulation of PMK-1 activity. Over-
all, intersection between the DAG-DKF-2 pathway and the p38
MAP-kinase cascade enables integrated regulation of innate
immunity by multiple stimuli.
TPA-1, a PKCd Homolog, Regulates DKF-2 In Vivo
C. elegans expresses three PKCs capable of regulating DKF-2.
PKC-2 is activated by DAG and Ca2+; PKC-1 and TPA-1 are
Immunity
PKD Regulates C. elegans Innate ImmunityTable 2. DKF-2 Activation Sharply Diminished Abundance of >40
mRNAs
Gene Family
and Sequence Name Gene Name Fold Induction
Stress Response
Y46H3A.2 hsp-16.41 0.17
Y46H3A.3 hsp-16.2 0.18
C12C8.1 hsp-70 0.10
K11G9.6 mtl-1 0.21
R11A8.4 sir-2.1 0.18
F25B5.4 ubq-1 0.24
ZK520.4 cul-2 0.27
F43C11.7 0.28
Signaling Proteins
T06E4.3 atl-1 0.24
C35C5.4 mig-2 0.04
H39E23.1 par-1 0.25
F54E7.3 par-3 0.25
T03D8.1 num-1 0.27
C43E11.3 met-1 0.18
R05D3.11 met-2 0.28
Nutrient Proteins
K09F5.2 vit-1 0.31
F59D8.2 vit-4 0.21
Spindle Formation
C33H5.4 klp-10 0.29
C06G3.2 klp-18 0.20
M7.2 klc-1 0.14
Helicases
T07D4.4a 0.18
T07D4.4b 0.21
C24H12.4a 0.24
E03A3.2 rcq-5 0.20
T08D2.3 0.27
Translation, RNA & DNA
E04D5.1b 0.26
K04G2.1 eIF-2b 0.31
C37C3.2 phi-18 0.27
F22B7.6 polk-1 0.29
C04E6.11 0.19
C25A1.3 tag-72 0.18
Y40D12A.1a 0.27
T08B2.5d 0.27
C53H9.2b 0.26
F13B10.2 rpl-3 0.29
ZK1127.9b 0.33
F26A3.3 ego-1 0.22
C16A3.1 0.20
T02G5.6 msh-4 0.31
Y73B3A.18a 0.31
W04D2.6a 0.22
F57B9.7b 0.17switched on by DAG alone (Islas-Trejo et al., 1997; Land et al.,
1994; Tabuse et al., 1995). We created homozygous null animals
lacking both PKC-1 and PKC-2 proteins. The double mutants
develop, feed, and reproduce normally. Viable, fertile C. elegans
homozygous for a severe loss-of-function mutation in TPA-1
(tpa-1(k530) allele) was obtained from the C. elegans Genetics
Center. Elimination of relevant PKCs will extinguish A-loop phos-
phorylation and activation of DKF-2, thereby generating a ‘‘dkf-2
null’’ phenotype in animals expressing normal or elevated
amounts of DKF-2.
Elimination of both PKC-1 and PKC-2 did not significantly
diminish survival of C. elegans fed with PA14 (Figure 4A). There-
fore, PKC-1 and PKC-2 are not critical regulators of DKF-2.
Inactivation of TPA-1, a PKCd homolog, shifted the survival curve
to mimic the dkf-2(pr3) null phenotype (Figure 4A). TPA-1
deficiency abolished enhanced innate immunity conferred by
DKF-2-GFP overexpression and again recapitulated a dkf-2 null
phenotype (Figure 4B). A classical interpretation of the genetic
analysis places TPA-1 downstream from DKF-2 in a common
pathway. However, the epistasis data are also compatible with
the idea that TPA-1 is an essential activator of endogenous WT
DKF-2 and overexpressed DKF-2-GFP. Results in Figure 4 do
not reveal which kinase is the upstream regulator and which is
the substrate effector. The ambiguity is resolved by extensive
biochemical evidence, which demonstrates conclusively that
PKCs switch on PKD (DKF-2) catalytic activity by phosphory-
lating the D kinase activation loop (A-loop) (Feng et al., 2007;
Rozengurt et al., 2005; Wang, 2006). Thus, we conclude that
TPA-1 uniquely regulates DKF-2 in intestinal cells in vivo. TPA-1
and DKF-2 are components of a signaling cascade that allows
DAG to regulate host responses to pathogens (Figure S7).
DISCUSSION
PKDs have been studied for more than 10 years, but little is
known about their regulation and functions in vivo. We discov-
ered that DKF-2 regulates gene expression that defends epithe-
lium against attack by bacterial pathogens. The PKD provides
a unique link between DAG-PKC-mediated signal transduction
and innate immunity.
C. elegans intestine governs many facets of immunity. Intes-
tinal DKF-2 is a critical component of a signaling pathway.
Signals flow through the pathway when pathogens or other
stimuli activate PLCs. PKC-1 (PKC3 homolog), PKC-2 (PKCb),
and TPA-1 (PKCd) are candidate DKF-2 activators in C. elegans
(Feng et al., 2007). PKCs a, b, d, 3, h, and q activate PKDs in
vertebrate cell lines (Rozengurt et al., 2005; Wang, 2006), sug-
gesting that D kinases are redundantly regulated. Analysis in
C. elegans provided a counterpoint to this concept. Gene disrup-
tion, cell-specific DKF-2 transgene expression, and epistasis
analysis revealed that TPA-1 exclusively regulates DKF-2
in vivo. Disruption of pkc-1 and pkc-2 genes did not affect
PA14-mediated killing of C. elegans. Thus, PKC-1 and PKC-2
effectors do not engage the immune system.
Microarray analysis measured the abundance of mRNAs in animals ex-
pressing an integrated dkf-2::dkf-2-Gfp transgene (relative to mRNA
levels in WT C. elegans).Immunity 30, 521–532, April 17, 2009 ª2009 Elsevier Inc. 527
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PKD Regulates C. elegans Innate ImmunityThe TPA-1-DKF-2 pathway is inactive in animals consuming
nonpathogenic food. Catalytic activities of endogenous DKF-2
and recombinant DKF-2-GFP are switched on by mild pathogen
(OP50) and more potently elevated by PA14 ingestion. Evidently,
mild and strong pathogens elicit corresponding increases in
Table 3. DKF-2-Induced mRNAs Are Upregulated by PA14
Infection; Expression of Pathogen-Induced Transcripts Is
Modulated by DKF-2 in Infected Animals
(A) mRNA Induction (fold)
dkf-2::dkf-2-Gfp PA14 infection (20 hr)
abf-2 26.5 40.5
arf-1.1 4.3 6.6
c14c6.5 5.5 nd
c49 g7.7 42.2 72.3
cdr-4 2.0 nd
clc-1 8.2 16.4
clec-52 38.9 2.3
f10a3.1 25.6 35.5
f21f8.4 2.2 6.3
f53e10.4 5.4 nd
fkh-9 4.9 10.4
gst-38 3.2 47.6
hda-4 2.5 2.0
k11h12.4 2.9 nd
m02f4.7 2.8 nd
nhr-63 3.8 6.3
nhx-6 3.4 7.0
nlp-29 3.1 2.1
spp-9 4.5 2.2
spp-18 17.1 18.5
y39b6a.24 1.2 1.0
(B) mRNA Induction (fold) in Infected Animals
dkf-2(pr3) N2 dkf-2::dkf-2-Gfp
f21f8.4 0.6 6.3 9.3
f53e10.4 25.8 30.6 70.8
arf1.1 3.3 5.7 10.7
clc-1 22.8 24.5 45.8
clec-52 1.3 2.3 14.7
fkh-9 17.1 17.4 22.6
nhx-6 2.2 4.1 6.6
spp-18 6.1 14.1 22.3
abf-2 29.5 36.7 44.4
nlp-29 2.3 2.0 5.6
nhr-63 5.4 6.3 10.6
(A) Induction of mRNAs caused by increased DKF-2 activity or PA14
infection. qRT-PCR data are normalized to actin mRNA and expressed
as fold-induction (mRNA concentration in transgenic or infected ani-
malsO mRNA concentration in WT animals); nd, not determined.
(B) Induction of mRNAs in DKF-2-deficient, WT, and transgenic (dkf-
2::dkf-2-Gfp) animals infected with PA14 (20 hr). Normalized qRT-PCR
data are expressed as fold-induction (mRNA concentration in indicated
infected animalsO mRNA concentration in uninfected animals). Experi-
ments in (A) and (B) were repeated twice, yielding similar results.528 Immunity 30, 521–532, April 17, 2009 ª2009 Elsevier Inc.DAG concentration and TPA-1 activity. The amount of PA14-
induced, DKF-2 kinase activity in WT animals matches the D
kinase activity in uninfected animals overexpressing DKF-2-
GFP. This amount of kinase activity elicits large inductions of
immune effector mRNAs. Thus, animals expressing elevated
DKF-2-GFP can generate antimicrobial proteins prior to infec-
tion. Kinase activity is further amplified 2.6-fold when transgenic
animals are fed PA14. Pre-existing antimicrobial proteins may
protect against PA14 during early phases of infection; a path-
ogen-induced increase in DKF-2-GFP catalytic activity could
enhance nematode survival during later stages of infection.
DKF-2 deficiency causes hypersensitivity to killing by PA14.
Thus, both activation and amount of DKF-2 are strongly linked
to C. elegans defense against pathogens. We conclude that
DKF-2, a PKD, is a physiologically relevant mediator of innate
immunity in normal cells in vivo.
DKF-2-GFP induced expression of 85 antipathogen genes by
3- to 30-fold. The corresponding proteins contribute to many
facets of innate immunity. Caenacins and structurally related
NLPs 28, 30, and 34 are secreted antimicrobial proteins (Pujol
et al., 2008). Saposins create pores in bacterial membranes
and promote catabolism of essential lipids. C-lectins bind
bacterial oligosaccharides, thereby generating complexes that
recruit enzymes that kill or inactivate bacteria (Nicholas and
Hodgkin, 2004). Activated DKF-2 increased expression of
genes involved in detoxification (glutathione-S-transferases),
proteolysis, and catabolite re-cycling. Some transporters trans-
locate nucleosides, nucleotides, inositol, carboxylic acids, and
sugars (potentially generated by extracellular and lysosome-
mediated degradation of bacterial constituents) into cytoplasm
where they are used for metabolism and synthesis of macro-
molecules.
Activated DKF-2 induced mRNAs encoding 12 proteins that
contain ShKT domains (Tudor et al., 1996). Most of these
proteins have signal sequences, suggesting that they are ex-
ported by exocytosis. Functions of C. elegans ShKT proteins
are unknown. However, mRNAs encoding ten ShKT proteins
increased in C. elegans infected with PA14 or M. nematophilum
(O’Rourke et al., 2006; Troemel et al., 2006). Five pathogen-
induced ShKT transcripts (F01D5.2, F01D5.3, F01D5.5,
F49F1.5, and T24B8.5) were also induced by elevated DKF-2.
Large increases in mRNAs encoding 21 uncharacterized
proteins were evident in transgenic animals. Predicted signal
sequences and/or transmembrane domains in the ‘‘unknown’’
proteins support the theme that DKF-2 upregulates secreted
and integral membrane proteins.
DKF-2 activation sharply increased claudin gene expression
(CLC-1 and F10A3.1). Claudins traverse plasma membrane
four times, stabilize cell-cell adhesion, and create pores that limit
the size of molecules diffusing between cells (Shin et al., 2006).
Increased claudin content will inhibit penetration of intestinal
epithelium by pathogens and paracellular diffusion of toxins
and noxious metabolites. DKF-2 elicited large increases in
SEDL-1, F45E4.1, and T02E1.7 mRNAs. The encoded proteins
share 50%–75% amino acid sequence similarity with human
TRS20, ARF-1, and SURF-4 proteins, respectively (Altan-Bonnet
et al., 2004; Gecz et al., 2003; Reeves and Fried, 1995). By
analogy, the C. elegans proteins may mediate transport of
protein cargo from Golgi membranes to plasma membrane
Immunity
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Figure 3. A-Loop Phosphorylation and PMK-1 Are Essential for Induction of Immune Effector mRNAs by DKF-2
(A) Survival curves for the indicated mutant and transgenic animals upon feeding with PA14.
(B) Amounts of 17 mRNAs were quantified (qRT-PCR) in animals expressing dkf-2::dkf-2-Gfp in WT or pmk-1(km25) null backgrounds. Fold-induction is: mRNA
concentration in a specified transgenic animalO mRNA concentration in WT C. elegans.
(C) Effects of DKF-2(Ala925Ala929)-GFP and DKF-2(Glu925Glu929)-GFP expression on concentrations of five mRNAs in a dkf-2(pr3) background. qRT-PCR data
are expressed as fold-induction.
(D) 30 mg total protein from the indicated WT, null, and transgenic strains ofC. elegans were assayed by immunoblot analysis. The blot was probed with anti-DKF-
2 IgGs; DKF-2 polypeptides were detected via chemiluminescence.
(E) A western blot (prepared as described in [D]) was probed with IgGs directed against the diphosphorylated A-loop of PMK-1 (Promega). Phospho-PMK-1 was
detected by chemiluminescence. 14-3-3 protein is a loading control. Experiments were performed three times, yielding similar results.and secretory vesicles. DKF-2 induces dozens of transmem-
brane and secreted antimicrobial proteins, so augmentation of
protein export machinery may be essential to mount an optimal
immune response.
Elevated DKF-2 elicited increases in mRNAs encoding MEF-2
(a transcription factor) and HDA-4, a type II HDAC. HDACs bind
and inactivate MEF2 isoforms in mammalian nuclei (Vega et al.,
2004). PKDs dissociate the complex by phosphorylating HDACs,
and derepressed MEF2 stimulates transcription of inducible
genes. Thus, DKF-2 and HDA-4-MEF-2 complexes may be
involved in dynamic regulation of gene transcription inC. elegans.
Fifty-one genes (61%) listed in Table 1 are expressed in the
intestine. Expression patterns of 30 genes (35%) are unknown.
Three highly induced mRNAs, encoding ABF-2 and two FMRFa-
mides (FLP-11 and FLP-22), are expressed in pharynx and
neurons, respectively, but not in intestine. The data suggest
that DKF-2 promotes innate immunity principally through actionsin intestinal cells. However, gene expression in nonintestinal cells
may be stimulated by indirect mechanisms. A logical speculation
is that DKF-2 activation triggers secretion of hormones from intes-
tinal cells. Hormone binding with receptors on other cell types
could elicit induction of specific mRNAs. For example, INS-7
secreted by intestinal cells controls DAF-16-mediated gene tran-
scription in muscle and hypodermis (Murphy et al., 2007).
Increased DKF-2 kinase activity sharply decreased expression
of many mRNAs. The encoded proteins mediate nonimmune
stress responses, chromatin modification, DNA checkpoint regu-
lation and repair, energy sensing, protein ubiquitinylation, and
oocyte differentiation. Gene expression patterns suggest that
DKF-2 suppresses normal homeostasis while maximizing
processes that favor survival during bacterial infection. Identities
of diminished mRNAs reveal that enhanced pathogen resistance
incurs a substantial cost, i.e., increased vulnerability to environ-
mental and biological insults.Immunity 30, 521–532, April 17, 2009 ª2009 Elsevier Inc. 529
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PKD Regulates C. elegans Innate ImmunityInduction of 75% of DKF-2-regulated mRNAs is codepen-
dent on PMK-1. Epistasis experiments place DKF-2 upstream
from PMK-1, so several steps may intervene between TPA-1-
mediated DKF-2 activation and differential mRNA accumulation.
Like mammalian p38 MAP-kinase, PMK-1 probably translocates
to the nucleus, where it phosphorylates and activates transcrip-
tion factors (Kyriakis and Avruch, 2001). Increased intestinal
DKF-2 activity elicits A-loop phosphorylation/activation of
PMK-1. The (previously unknown) convergence of PKD (DKF-2)
signaling with the p38 MAP-kinase cascade incorporates
PMK-1 into a PLC-DAG-controlled network.
The DKF-2 target in the PMK-1 pathway is unknown. In
mammalian endothelial cells, PKD facilitates activation of
ASK-1, an NSY-1 homolog (Zhang et al., 2005). However, neither
A-loop phosphorylation nor catalytic activity of PKD was
required to activate ASK-1. In contrast, DKF-2 phosphoryla-
tion/activation is essential for induction of immune effector
mRNAs. DKF-2 might phosphorylate upstream pathogen recog-
nition receptors (currently unknown in C. elegans), TIR-1 (Toll-
IL-1 receptor domain protein that stimulates NSY-1), or down-
stream protein kinases in the PMK-1 pathway (Liberati et al.,
2004). DKF-2 might also mediate inactivation of VHP-1, a protein
phosphatase that quenches PMK-1 activity (Kim et al., 2004).
Our studies indicate that DAF-16 is not a DKF-2-regulated
immune effector. A previous report supports this conclusion
(Troemel et al., 2006). Microarray and qRT-PCR analyses
revealed that PMK-1 is required for PA14-induced expression
of >20 immune effector genes. DAF-16 had little impact on upre-
gulation of PA14-PMK-1-induced mRNAs and was not required
for innate immune responses in a WT background. Increased
A
B
Figure 4. TPA-1 Controls DKF-2
(A) Survival curves for dkf-2(pr3) null, pkc-1(ok563);pkc-2(ok328) double null,
and tpa-1(k530)-defective C. elegans mutants feeding on PA14.
(B) Survival curves for WT, dkf-2(pr3), and transgenic (dkf-2::dkf-2-Gfp and
tpa-1(k530);dkf-2::dkf-2-Gfp) nematodes fed PA14.530 Immunity 30, 521–532, April 17, 2009 ª2009 Elsevier Inc.DAF-16 activity promoted resistance to PA14 in a daf-2 mutant
background. However, pathogen resistance was attributed to
a general stress response (and parallel pathway) that does not
affect induction of immune effector mRNAs.
Little is known about roles of PKDs in mammalian innate
immunity. However, several reports support parts of the model
proposed in Figure S7. Enteropathogenic E. coli elicits PKC acti-
vation in T84 intestinal epithelial cells (Crane and Oh, 1997). After
binding pathogen flagellar proteins, Toll-like receptor 5 (TLR-5)
transduces signals that stimulate secretion of IL-8, an inflamma-
tory cytokine, by epithelial cells. PKD phosphorylates (in vitro)
a potential regulatory site in the TLR-5 cytoplasmic domain
and a TLR-5-PKD complex was isolated from transfected
HEK293 cells (Ivison et al., 2007). TLR-5-induced IL-8 secretion
was dependent on PKD and p38 MAP kinase. However, PKD
was not activated when TLR-5 bound flagellin. Thus, classical
regulatory roles for PKCs and PKD were excluded.
In HeLa and MDCK cells, PKDs phosphorylate and activate
PI4-Kinase IIIb (PI4KIIIb) on Golgi membranes. This triggers
fission of TGN vesicles that deliver protein cargo to plasma
membrane and secretory vesicles (Hausser et al., 2005). The lipid
kinase generates PI4P, which is cleaved by PLCs to yield DAG;
elevated DAG elicits TGN membrane invagination and vesicle
fission (Bard and Malhotra, 2006). Many DKF-2-induced mRNAs
encode secreted or integral membrane proteins. DKF-2 may
couple a surge in protein export to an increase in cargo transport
capacity by stimulating synthesis of ARF-1, TRS20, and SURF-4.
These proteins can control rates and levels of protein export from
TGN. ARF-1 also governs association of PI4KIIIbwith Golgi mem-
branes and partially activates the lipid kinase (Godi et al., 1999);
subsequent phosphorylation by colocalized PKD yields maxi-
mally active PI4KIIIb. ARF-1 activates phospholipase D, thereby
generating phosphatidic acid (PA). Conversion of PA to DAG, by
a lipid phosphatase, promotes further TGN invagination and
PI4KIIIb activation (Bard and Malhotra, 2006). Emerging parallels
between the model in Figure S7 and observations made with
mammalian cells suggest that studies on roles of PKDs in verte-
brate innate immunity will be worthwhile endeavors.
EXPERIMENTAL PROCEDURES
Strains
The C. elegans Genetics Center provided pmk-1(km25) null and tpa-1(k530)
(severe loss-of-function) mutants. pkc-1(ok563), pkc-2(ok328), and dkf-2(pr3)
null mutants were obtained from the C. elegans Knockout Consortium (Van-
couver, BC). Animals carrying chromosomally integrated copies dkf-2::Gfp,
dkf-2::dkf-2-Gfp, dkf-2::dkf-2(Ala925Ala929)-Gfp, and dkf-2::dkf-2(Glu925-
Glu929)-Gfp transgenes and pkc-1(ok563);pkc-2(ok328) double null mutants
were generated via standard protocols. Mutants were backcrossed (63) into
WT background.
Construction of Transgenes
A 1.4 kb segment of genomic DNA that flanks the 50 end of the dkf-2 gene was
synthesized by PCR. DNA was cloned into a C. elegans NLS-GFP reporter
vector (pPD95.70) as previously described (Feng et al., 2006b) to generate
dkf-2::GFP. cDNA encoding DKF-2 (clone yk417d2) was obtained from the
Japanese C. elegans EST project. A 3.7 kb cDNA fragment (in pBluescript),
which includes a portion of exon 2 and all other dkf-2 exons, was coupled,
in-frame with 1.4 kb of 50 flanking DNA, exon I, and the missing part of exon
2 via ligation at a unique XhoI site. Recombined DNA was cloned into a PstI-
SmaI-digested GFP reporter vector (pPD95.79), yielding dkf-2::dkf-2-Gfp.
Immunity
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P. aeruginosa (PA14) was seeded on agar plates containing C. elegans growth
medium. A group of 100 or 120 synchronized L4 animals was transferred from
normal food (E. coli OP50) to PA14 pathogen plates. Plates were incubated at
25C and the number of living worms was determined at 8 hr intervals. Immo-
bile worms unresponsive to touch were scored as dead. Statistical analyses of
survival curves are presented in Table S10.
Preparation of RNA
WT, mutant, and transgenic C. eleganswere grown and synchronized as previ-
ously described (Land et al., 1994). Total RNA was extracted from young adult
animals with TRIZOL Reagent (Invitrogen) according to the manufacturer’s
protocol. RNA was purified on an RNeasy column (QIAGEN).
Microarray Analysis
Probes for DNA microarray hybridization were prepared with the SuperScript
Plus RT-cDNA Labeling System (Invitrogen). Total RNA (20 mg) from WT and
transgenic (dkf-2::dkf-2-Gfp, WT background) C. elegans were used as
templates for synthesis of Cy3- and Cy5-labeled cDNAs, respectively. Micro-
array slides and hybridization protocols were obtained from Washington
University (St. Louis, MO). cDNAs were hybridized with a slide containing
60-mer oligonucleotides representing transcripts encoded by all (22,000)
C. elegans genes. After washing, Cy5 and Cy3 fluorescence intensities were
recorded with a Gene Pix 400A scanner, normalized, and analyzed with
Gene Pix Pro 6.0 software. High Cy5:Cy3 values identified mRNAs induced
by DKF-2; low ratios revealed repressed mRNAs. Assays were replicated three
times, with independently isolated RNA. Microarray data sets are provided in
Tables S1–S7.
Quantitative Real-Time PCR Analysis
RNA from various C. elegans strains was used as a template for cDNA
synthesis catalyzed by SuperScript III reverse transcriptase (Invitrogen).
cDNA was serially diluted and qRT-PCR was performed, via SYBR green
detection in combination with the Roche LightCycler System and software.
The delta Ct method was used to calculate fold-induction; the efficiency of
PCR reactions was 1.89 to 1.95 (i.e., 95%–98%) in all experiments. Data
were normalized to the invariant level of ACT-1 mRNA. qRT-PCR primers
were designed with Primer3 software and checked against C. elegans
genomic DNA for specificity. Statistical data (means, SEM, and p values) for
qRT-PCR measurements are given in Tables S8 and S9.
Immunoprecipitation and In Vitro Kinase Assays
C. elegans or transfected cells were disrupted in buffer containing 1% Triton
X-100 as previously described (Feng et al., 2007). DKF-2 or DKF2-GFP was
precipitated with affinity-purified antibodies and catalytic activity was quanti-
fied by measuring incorporation of 32P radioactivity from [g-32P]ATP into Syn-
tide-2 as previously reported (Feng et al., 2007).
Other Procedures
Descriptions of transfection experiments, characterization of gene deletions,
generation and selection of transgenic animals, immunofluorescence micros-
copy, mutagenesis, denaturing electrophoresis, antibody production and
characterization, and western immunoblot analysis are given in previous
papers (Feng et al., 2006a, 2006b, 2007).
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